Genomic Classifier Tests Play Heterogeneous Role in Prostate Cancer Risk Classification
TUESDAY, Jan. 21, 2025 (HealthDay News) -- For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk classification or tre...